Italian Journal of Anatomy and Embryology - contenuto non piu disponibile
Carmen Mecca, Ileana Giambanco, Rosario Donato, Cataldo Arcuri
0 citations
Carmen Mecca
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
39Publications signalées
1002Citations signalées
2Affiliations récentes
Les institutions déclarées
Les domaines associés
Lung Cancer Treatments and MutationsCAR-T cell therapy researchNeuroinflammation and Neurodegeneration MechanismsCancer Immunotherapy and BiomarkersLymphoma Diagnosis and Treatment
Les publications récentes
Abstract 5619: First-in-class anaplastic lymphoma kinase (ALK)-specific TCR-T cells induce potent and selective antitumor immunity across ALK-driven human cancers
Carmen Mecca, Simone Piane, Nirmala Tilija Pun, Ana Azambuja et autres
us, it (code pays fourni par la source)
1 citation
Cancer Research
Abstract 6716: ALK-mRNA vaccine as a new Immunotherapy for ALK+ cancers
Gabriele Saccu, Alessandro Gasparetto, Carmen Mecca, Elisa Bergaggio et autres
us (code pays fourni par la source)
1 citation
Cancer Research
Abstract 1542: ALK expression identifies a therapeutically targetable subset of Merkel cell carcinomas responsive to ALK.CAR-T cell therapy alone or in combination with ALK inhibitors
Alessandro Gasparetto, Jasna Metović, Elisa Landoni, Carmen Mecca et autres
us, it (code pays fourni par la source)
0 citations
Cancer Research
Abstract 5615: ALK-specific TCR-T cells showed potent and specific activity in ALK-positive anaplastic large cell lymphoma
Simone Piane, Carmen Mecca, Nirmala Tilija Pun, Ana Azambuja et autres
us (code pays fourni par la source)
0 citations
Cancer Research
Development of ALK-directed TCR-T cells with potent and specific anti-tumor activity against ALK-positive anaplastic large cell lymphoma
Simone Piane, Carmen Mecca, Nirmala Tilija Pun, Ana Paula Azambujá et autres
us, it (code pays fourni par la source)
2 citations
Blood
225 ALK.CAR-T cells as a new potential treatment for ALK + merkel cell carcinoma
Alessandro Gasparetto, Jasna Metović, Elisa Landoni, Carmen Mecca et autres
us, it (code pays fourni par la source)
0 citations
Regular and Young Investigator Award Abstracts
1297 ALK-mRNA vaccine as a new immunotherapy for ALK+ cancers
Gabriele Saccu, Alessandro Gasparetto, Carmen Mecca, Elisa Bergaggio et autres
us, it (code pays fourni par la source)
0 citations
Regular and Young Investigator Award Abstracts
Abstract B071: ALK.CAR-T cells as a new potential treatment for ALK+ Merkel cell carcinoma
Alessandro Gasparetto, Jasna Metović, Elisa Landoni, Carmen Mecca et autres
it, us (code pays fourni par la source)
0 citations
Molecular Cancer Therapeutics
Verso una nuova cultura giudiziaria dei legami familiari
0 citations
MINORIGIUSTIZIA
ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cells
Chiara Ambrogio, Manuel Nüesch, Elisa Landoni, Tongqing Li et autres
us (code pays fourni par la source)
0 citations
Carolina Digital Repository (University of North Carolina at Chapel Hill)
438 Development of ALK TCR-T therapy against ALK-positive human cancers
Carmen Mecca, Simone Piane, Ana Paula Azambujá, Luca Alessandrì et autres
us (code pays fourni par la source)
0 citations
Regular and Young Investigator Award Abstracts
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.